Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases
Ralf Ludwig, Director of the Lübeck Institute of Experimental Dermatology at the University of Lübeck, shared a post on LinkedIn:
”New Research Topic at Frontiers in Immunology – and we want your best RWD and immunology work.
‘Real-world advances in inflammatory diseases: from population data to immunological mechanisms and clinical impact’
The premise: Population-scale data is most powerful when paired with mechanistic insight.
We’re looking for studies that do both – whether that’s comparative effectiveness of biologics, immune biomarkers at scale, comorbidity mapping, or methods work on causal inference in observational cohorts.
TriNetX, UK Biobank, NHIRD, Clalit, national registries – all welcome.
Editors: Shuo-Yan Gau (Charité), Ralf Ludwig (Lübeck), Uazman Alam (Liverpool), Philip Curman (Karolinska).
Deadline for submission – 4 December 2026.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 21:19Ahmed Koriesh: Join Us for Future of Stroke Care 2026
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV
-
Jun 23, 2026, 19:20Simos Kokkovos: 1st Ever Mobile Stroke Unit in Greece is on its way to Metropolitan Hospital